PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1. (Q39032412)
Jump to navigation
Jump to search
scientific article published on 21 January 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1. |
scientific article published on 21 January 2014 |
Statements
1 reference
PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1. (English)
1 reference
Shuyu Zhang
1 reference
Xiaodong Yang
1 reference
Judong Luo
1 reference
Xin Ge
1 reference
Wanping Sun
1 reference
Hong Zhu
1 reference
Weiping Zhang
1 reference
Jianping Cao
1 reference
Yinglong Hou
1 reference
21 January 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference